Holen Sie sich die Stockscreener-App
0.20
67.65%
-0.4183
Handel nachbörslich:
.24
0.04
+20.00%
Schlusskurs vom Vortag:
$0.6183
Offen:
$0.6574
24-Stunden-Volumen:
34.99M
Relative Volume:
45.70
Marktkapitalisierung:
$4.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-61.17%
1M Leistung:
-61.07%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.185
$0.714
1-Wochen-Bereich:
$0.185
$0.714
52-Wochen-Spanne:
$0.185
$1.09
Ping An Biomedical Co Ltd Stock (PASW) Company Profile
Firmenname
Ping An Biomedical Co Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PASW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASW
Ping An Biomedical Co Ltd
|
0.20 | 12.68M | 0 | 0 | 0 | 0.00 |
|
AIN
Albany International Corp
|
56.70 | 1.58B | 1.27B | 100.39M | 116.84M | 3.20 |
|
UFI
Unifi Inc
|
3.59 | 70.32M | 583.56M | -53.59M | -18.48M | -2.97 |
|
CULP
Culp Inc
|
3.46 | 44.07M | 237.23M | -13.64M | -6.50M | -1.10 |
Ping An Biomedical Co Ltd Aktie (PASW) Neueste Nachrichten
United States shares higher at close of trade; Dow Jones Industrial Average up 0.48% By Investing.com - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com
United States shares higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com India
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session - Benzinga
Future Biotechnology Group Co., Ltd announced that it expects to receive $90 million in funding from Ping An Biomedical Co., Ltd. - MarketScreener
Ping An Biomedical Co., Ltd. announced a financing transaction - MarketScreener
Ping An Biomedical (PASW) Stock: Gains Strategic Investors While Addressing Nasdaq Compliance - parameter.io
11 Consumer Discretionary Stocks Moving In Friday's Intraday Session - Benzinga
Ping An Biomedical stock plunges after announcing $90 million investment plan By Investing.com - Investing.com
Remedy’s Nutrition® Unveils Hair Tissue Mineral Analysis: A Revolutionary Personalized Approach to Nutritional Wellness - The Manila Times
Ping An Bio to invest $90 million in Future Biotechnology Group By Investing.com - Investing.com South Africa
Shopley Announces Steve Levely as Chief Executive Officer - The Manila Times
Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results - The Manila Times
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth - The Manila Times
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry - The Manila Times
Sienna Announces Fourth Quarter 2025 Results Release Date and Conference Call - The Manila Times
Greenstone Files Early Warning Report for Marimaca Copper Corp. - The Manila Times
ACTG Launches IPACE-HIV to Study Frailty Intervention - The Manila Times
ProMach Acquires American Holt, DMA Solution, and Pride Engineering from Arcline - The Manila Times
Ping An Biomedical secures investment from three notable investors By Investing.com - Investing.com Nigeria
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026 - The Manila Times
uniQure Announces Type A Meeting Scheduled with FDA - The Manila Times
La Rosa Holdings Corp. Announces Closing of Initial Funding Under $250 Million Note Facility as Part of $1.25 Billion AI Infrastructure Program - The Manila Times
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation - The Manila Times
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference - The Manila Times
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker 'LONA” - The Manila Times
H&R Block Tax Pro Review Free for New Clients with Purchase of DIY Products - The Manila Times
Nobel Announces Non-Brokered Private Placement Offering - The Manila Times
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - The Manila Times
Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, January 27, 2026 - The Manila Times
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger - The Manila Times
Mutuum Finance's Phase 7 is Surging as MUTM Growth Exceeds 300% Growth Since 2025 - The Manila Times
Aurora Mobile Partners with Xiaoe to Enhance Interaction Efficiency and Support Sustainable Growth in Private Domain Ecosystems - The Manila Times
VR Upsizes Brokered Private Placement Led by Centurion One Capital to $1,500,000 - The Manila Times
Predis.ai Announces Launch of New State-of-the-Art (SOTA) AI Models for Ad Videos - The Manila Times
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 - The Manila Times
ASHTON WOODS USA L.L.C. ANNOUNCES QUARTERLY RESULTS CONFERENCE CALL - The Manila Times
Why China tech investors are backing this biomedical AI push - Stock Titan
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session - Benzinga
FLYEXCLUSIVE INC. (FLYX) Stock, Price, News, Quotes, Forecast and Insights - MSN
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session - Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session - Benzinga
Ping An Biomedical Co., Ltd. (MJID) Competitors - Meyka
Ping An Biomedical Co., Ltd. (MJID) Alternative Data AnalyticsSocial & Digital Signals - Meyka
Kandal M Venture Limited (FMFC) Stock, Price, News, Quotes, Forecast and Insights - MSN
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session - Benzinga
Ping An Biomedical Faces Nasdaq Listing Compliance Challenge - MSN
Kandal M Venture Ltd (FMFC) - MSN
Finanzdaten der Ping An Biomedical Co Ltd-Aktie (PASW)
Es liegen keine Finanzdaten für Ping An Biomedical Co Ltd (PASW) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):